Private Portfolio Partners LLC Oramed Pharmaceuticals Inc. Transaction History

Private Portfolio Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$5.88 - $12.03 $81,144 - $166,014	-13,800 Reduced 20.47%	53,600 $644,000
Q3 2022 Mar 14, 2023	BUY	$4.6 - $9.91 $61,593 - $132,694	13,390 Added 24.79%	67,400 $454,000
Q3 2022 Nov 07, 2022	BUY	$4.6 - $9.91 $61,593 - $132,694	13,390 Added 24.79%	67,400 $437,000
Q2 2022 Mar 14, 2023	BUY	$3.72 - $9.0 $43,747 - $105,840	11,760 Added 27.83%	54,010 $247,000
Q2 2022 Aug 02, 2022	BUY	$3.72 - $9.0 $43,747 - $105,840	11,760 Added 27.83%	54,010 $247,000
Q1 2022 Mar 14, 2023	SELL	$8.19 - $13.89 $92,956 - $157,651	-11,350 Reduced 21.18%	42,250 $365,000
Q1 2022 May 12, 2022	BUY	$8.19 - $13.89 $346,027 - $586,852	42,250 New	42,250 $365,000

6.37M

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $91.2M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Private Portfolio Partners LLC with notifications on news.